XOMA (XOMAP) News Today $25.34 0.00 (0.00%) Closing price 05/22/2026 03:53 PM EasternExtended Trading$25.38 +0.04 (+0.14%) As of 05/22/2026 04:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendHeadlinesSEC FilingsShort InterestTrendsBuy This Stock XOMAP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Xoma AB Series B54 minutes ago | barrons.comXOMA royalty (XOMA) price target decreased by 32.32% to 45.39May 14, 2026 | msn.comHC Wainwright & Co. downgrades XOMA Royalty (XOMA)April 30, 2026 | msn.comLGND: XOMA Buy Adds 100+ AssetsApril 29, 2026 | finance.yahoo.comLigand to buy XOMA Royalty for $39/shareApril 27, 2026 | msn.comWe Believe XOMA Royalty's (NASDAQ:XOMA) Earnings Are A Poor Guide For Its ProfitabilityMarch 26, 2026 | finance.yahoo.comXOMA Royalty Corporation: XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business AchievementsMarch 18, 2026 | finanznachrichten.deXOMA shares climb after Q4 results top forecasts on strong royalty incomeMarch 18, 2026 | msn.comXOMAP XOMA Royalty Corporation 8.625% CUM PERP PFD SER AMarch 5, 2026 | seekingalpha.comGeneration Bio pays landlord $21.5M to escape lease early after Xoma buyoutFebruary 10, 2026 | bizjournals.comXoma to acquire Generation Bio for $4.2913 per shareDecember 16, 2025 | msn.com‘Zombie’ biotech buyer Xoma to acquire Generation BioDecember 16, 2025 | finance.yahoo.comLucid Capital Markets initiates coverage of XOMA Royalty Corporation - preferred stock (XOMAP) with buy recommendationDecember 10, 2025 | msn.comXOMA Royalty Corporation: XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.November 21, 2025 | finanznachrichten.deEarnings Beat: XOMA Royalty Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsNovember 15, 2025 | finance.yahoo.comLava Therapeutics announces intent to delist from NasdaqNovember 13, 2025 | msn.comBioInvent International AB: Interim Report January - June 2025August 26, 2025 | finance.yahoo.comLAVA Therapeutics N.V.: LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 14, 2025 | finanznachrichten.deXOMA-Backed XenoTherapeutics to Acquire Essa PharmaJuly 14, 2025 | marketwatch.comXOMA To Acquire Turnstone Biologics For $0.34/Shr Plus Contingent Value Right - NasdaqJune 29, 2025 | nasdaq.comResults: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its EstimatesMay 16, 2025 | finance.yahoo.comBenchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy RecommendationApril 17, 2025 | msn.comTrimble, Xoma announce new collaborationMarch 11, 2025 | markets.businessinsider.comXoma royalty corp sees sale of $16.98 million in stock by investorsJanuary 28, 2025 | msn.comXOMA Royalty CorporationJanuary 24, 2025 | seekingalpha.comXoma price target raised to $123 from $117 at H.C. WainwrightDecember 4, 2024 | markets.businessinsider.comXoma Royalty acquires Pulmokine for $20MDecember 2, 2024 | markets.businessinsider.comXOMA Royalty Corporation (XOMAP)November 21, 2024 | nz.finance.yahoo.comXoma’s Strategic Developments and Financial Performance Drive Buy Rating and Increased Price TargetNovember 11, 2024 | markets.businessinsider.comXoma (XOMA) Gets a Hold from TD CowenNovember 8, 2024 | markets.businessinsider.comXOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent ActivitiesNovember 7, 2024 | markets.businessinsider.comXOMA Royalty: Q3 Earnings SnapshotNovember 7, 2024 | finance.yahoo.comInvestors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past yearOctober 21, 2024 | finance.yahoo.comParty Time: Brokers Just Made Major Increases To Their XOMA Royalty Corporation (NASDAQ:XOMA) Earnings ForecastsAugust 18, 2024 | finance.yahoo.comDaré Bioscience, Inc. (NASDAQ:DARE) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.comXOMA Royalty: Q2 Earnings SnapshotAugust 13, 2024 | finance.yahoo.comXOMA Royalty Corporation (XOMA) Stock Price, News, Quote & History - Yahoo FinanceAugust 9, 2024 | ca.finance.yahoo.comCUE Aug 2024 3.000 call (CUE240816C00003000)August 4, 2024 | finance.yahoo.comCUE Aug 2024 4.000 put (CUE240816P00004000)August 4, 2024 | finance.yahoo.comXOMA Royalty Corporation (XOMA)July 30, 2024 | finance.yahoo.comBuy Rating Affirmed for Xoma with Enhanced Price Target Reflecting New Royalty Assets and Growth ProspectsMay 14, 2024 | markets.businessinsider.comLeerink Partners Initiates Coverage of XOMA (XOMA) with Outperform RecommendationApril 30, 2024 | msn.comXOMA Corporation 8.625% Series A Cumulative Perpetual Preferred StockApril 17, 2024 | thestreet.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendMarch 21, 2024 | msn.comAdhoc: Kuros Biosciences AG: Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023March 13, 2024 | finanznachrichten.deAnalysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX)March 11, 2024 | markets.businessinsider.comCox Communications wins order overturning $1 billion US copyright verdictFebruary 23, 2024 | msn.comXOMA Jun 2024 20.000 putFebruary 17, 2024 | finance.yahoo.comXOMA Sep 2024 12.500 putFebruary 17, 2024 | finance.yahoo.comStrategic Acquisitions and Royalty Income Streams Justify Buy Rating for XomaFebruary 16, 2024 | markets.businessinsider.com Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XOMAP Media Mentions By Week XOMAP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMAP News Sentiment▼0.000.47▲Average Medical News Sentiment XOMAP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMAP Articles This Week▼01▲XOMAP Articles Average Week Get the Latest News and Ratings for XOMAP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for XOMA and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ainos News Celularity News enGene News Fortress Biotech News Humacyte News Jasper Therapeutics News Neonc Technologies News Rocket Pharmaceuticals News Trinity Biotech News XOMA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMAP) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
